Stay updated on Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study page now displays Revision: v3.6.4, replacing the previous revision tag to reflect the latest version of the page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe revision tag on the page changed from v3.6.2 to v3.6.3. This reflects a minor version update and does not modify study details or user actions.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a backend update; the change does not alter displayed trial information.SummaryDifference0.0%

- Check53 days agoChange DetectedRecruitment status now indicates no longer looking for participants. New navigation and help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, the Intervention/Treatment header formatting was adjusted, and the page revision was updated to v3.6.0.SummaryDifference0.3%

- Check60 days agoChange DetectedThe page’s revision number was updated from v3.5.4 to v3.5.5, indicating a minor update to the record’s metadata.SummaryDifference0.0%

- Check81 days agoChange DetectedPublications entries were updated. The Sharma et al. CheckMate 032 Lancet Oncology paper was added with its citation, and the prior erratum reference was replaced with a revised entry (version 3.5.4).SummaryDifference0.1%

Stay in the know with updates to Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.